News
News from us and our partners
Tags
Topics
0 results
- News
Ingenix Publishes Benchmarks for Thalamus Decision, World's-First Typed-Decision Biological Model Capable of Interpreting Gene-Expression Data
- News
Danish biotech specialist raises €20 million to accelerate market-ready trait development
- News
Sofinnova Partners closes €725M Crossover II Fund
- News
Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation
- News
Mironid strengthens Board and clinical team to support next phase of growth
- News
Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia
- News
Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG
- News
Polish AI Start-up Claims First Place on LongevityBench and Open-Sources a Version of its Thalamus Reasoning Model
- News
Tenpoint Therapeutics Launches the YUVEZZI™ Telehealth Prescribing Program
- News
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
- News
AFYREN and MINASOLVE Announce Partnership Agreement to Jointly Develop Key Bio-Based Molecules for the Fragrances Industry at Industrial Scale
- News
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
- News
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
- News
Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands
- News
BrightHeart Expands Its AI Platform in Europe to Bring Greater Confidence and Consistency to Prenatal Ultrasound